Literature DB >> 22101351

Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia.

Angélique Biancotto1, Pradeep K Dagur, John C Fuchs, Adrian Wiestner, C Bruce Bagwell, J Philip McCoy.   

Abstract

Increased numbers of T regulatory (T(reg)) cells are found in B-chronic lymphocytic leukemia, but the nature and function of these T(regs) remains unclear. Detailed characterization of the T(regs) in chronic lymphocytic leukemia has not been performed and the degree of heterogeneity of among these cells has not been studied to date. Using 15-color flow cytometry we show that T(reg) cells, defined using CD4, CD25, and forkhead box P3 (FOXP3), can be divided into multiple complex subsets based on markers used for naïve, memory, and effector delineation as well as markers of T(reg) activation. Furthermore FOXP3(+) cells can be identified among CD4(+)CD25(-) as well as CD8(+)CD4(-) populations in increased proportions in patients with chronic lymphocytic leukemia compared with healthy donors. Significantly different frequencies of naïve and effector T(regs) populations are found in healthy donor controls compared with donors with chronic lymphocytic leukemia. A population of CCR7(+)CD39(+) T(regs) was significantly associated with chronic lymphocytic leukemia. This population demonstrated slightly reduced suppressive activity compared with total T(regs) or T(regs) of healthy donors. These data suggest that FOXP3-expressing cells, particularly in patients with chronic lymphocytic leukemia are much more complex for T(reg) sub-populations and transitions than previously reported. These findings demonstrate the complexity of regulation of T-cell responses in chronic lymphocytic leukemia and illustrate the use of high-dimensional analysis of cellular phenotypes in facilitating understanding of the intricacies of cellular immune responses and their dysregulation in cancer.

Entities:  

Mesh:

Year:  2011        PMID: 22101351      PMCID: PMC3512204          DOI: 10.1038/modpathol.2011.164

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  47 in total

1.  Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.

Authors:  A M Thornton; E M Shevach
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo.

Authors:  Clare Baecher-Allan; Julia A Brown; Gordon J Freeman; David A Hafler
Journal:  Novartis Found Symp       Date:  2003

3.  Inhibition of human CD4(+)CD25(+high) regulatory T cell function.

Authors:  Clare Baecher-Allan; Vissia Viglietta; David A Hafler
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

4.  Altered pattern of cytokine production by peripheral blood CD2+ cells from B chronic lymphocytic leukemia patients.

Authors:  E Reyes; A Prieto; F Carrión; J García-Suarez; F Esquivel; C Guillén; M Alvarez-Mon
Journal:  Am J Hematol       Date:  1998-02       Impact factor: 10.047

5.  Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.

Authors:  Wendelina J M Mackus; Florine N J Frakking; Annette Grummels; Laila E Gamadia; Godelieve J De Bree; Dorte Hamann; Rene A W Van Lier; Marinus H J Van Oers
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

Review 6.  Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.

Authors:  S Scrivener; R V Goddard; E R Kaminski; A G Prentice
Journal:  Leuk Lymphoma       Date:  2003-03

7.  Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells.

Authors:  Eva-Maria Weiss; Angelika Schmidt; Diana Vobis; Natalio Garbi; Katharina Lahl; Christian T Mayer; Tim Sparwasser; Andreas Ludwig; Elisabeth Suri-Payer; Nina Oberle; Peter H Krammer
Journal:  J Immunol       Date:  2011-07-11       Impact factor: 5.422

8.  Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.

Authors:  L S Taams; J Smith; M H Rustin; M Salmon; L W Poulter; A N Akbar
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

9.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

10.  Expansion of T cells expressing low CD4 or CD8 levels in B-cell chronic lymphocytic leukemia: correlation with disease status and neoplastic phenotype.

Authors:  U Dianzani; P Omedè; F Marmont; D DiFranco; A Fusaro; M Bragardo; V Redoglia; F Giaretta; L Mairone; M Boccadoro
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

View more
  14 in total

1.  Issue Highlights - September 2016.

Authors:  J P McCoy
Journal:  Cytometry B Clin Cytom       Date:  2016-09       Impact factor: 3.058

2.  Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander?

Authors:  Giovanni D'Arena; Vittorio Simeon; Fiorella D'Auria; Teodora Statuto; Paola Di Sanzo; Laura De Martino; Aurelio Marandino; Michele Sangiorgio; Pellegrino Musto; Vincenzo De Feo
Journal:  Am J Blood Res       Date:  2013-01-17

Review 3.  Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions.

Authors:  Farhad Jadidi-Niaragh; Ghasem Ghalamfarsa; Mehdi Yousefi; Mina Hajifaraj Tabrizi; Fazel Shokri
Journal:  Tumour Biol       Date:  2013-05-17

Review 4.  Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.

Authors:  Yair Herishanu; Ben-Zion Katz; Andrew Lipsky; Adrian Wiestner
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

5.  Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.

Authors:  Carsten U Niemann; Sarah E M Herman; Irina Maric; Julio Gomez-Rodriguez; Angelique Biancotto; Betty Y Chang; Sabrina Martyr; Maryalice Stetler-Stevenson; Constance M Yuan; Katherine R Calvo; Raul C Braylan; Janet Valdez; Yuh Shan Lee; Deanna H Wong; Jade Jones; Clare Sun; Gerald E Marti; Mohammed Z H Farooqui; Adrian Wiestner
Journal:  Clin Cancer Res       Date:  2015-12-09       Impact factor: 12.531

Review 6.  Studying the human immunome: the complexity of comprehensive leukocyte immunophenotyping.

Authors:  Angélique Biancotto; J Philip McCoy
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 7.  Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies.

Authors:  Giovanni D'Arena; Candida Vitale; Marta Coscia; Agostino Festa; Nicola Matteo Dario Di Minno; Vincenzo De Feo; Michele Caraglia; Gioacchino Calapai; Luca Laurenti; Pellegrino Musto; Giovanni Di Minno; Daniela Fenoglio
Journal:  J Immunol Res       Date:  2017-12-21       Impact factor: 4.818

8.  Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy.

Authors:  Meghali Goswami; Gabrielle Prince; Angelique Biancotto; Susan Moir; Lela Kardava; Brian H Santich; Foo Cheung; Yuri Kotliarov; Jinguo Chen; Rongye Shi; Huizhi Zhou; Hana Golding; Jody Manischewitz; Lisa King; Lauren M Kunz; Kimberly Noonan; Ivan M Borrello; B Douglas Smith; Christopher S Hourigan
Journal:  J Transl Med       Date:  2017-07-10       Impact factor: 5.531

9.  Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.

Authors:  Serena De Matteis; Chiara Molinari; Giulia Abbati; Tania Rossi; Roberta Napolitano; Martina Ghetti; Andrea Ghelli Luserna Di Rorà; Gerardo Musuraca; Alessandro Lucchesi; Gian Matteo Rigolin; Antonio Cuneo; Daniele Calistri; Pier Paolo Fattori; Massimiliano Bonafè; Giovanni Martinelli
Journal:  J Transl Med       Date:  2018-06-20       Impact factor: 5.531

10.  Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia.

Authors:  Patricia A Toniolo; Suhu Liu; Jennifer E Yeh; Darwin Q Ye; José Alexandre M Barbuto; David A Frank
Journal:  Oncotarget       Date:  2016-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.